COMERICA BANK - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMERICA BANK ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,009,461
+100946000.0%
37,051
+27.9%
0.01%
Q2 2023$1
-99.9%
28,972
-45.0%
0.00%
-100.0%
Q4 2022$1,208
-99.9%
52,695
-23.5%
0.01%
-47.1%
Q3 2022$1,995,000
-7.4%
68,840
-11.1%
0.02%
-5.6%
Q2 2022$2,154,000
+20.5%
77,410
-0.5%
0.02%
+38.5%
Q1 2022$1,788,000
+28.7%
77,780
-2.5%
0.01%
+30.0%
Q4 2021$1,389,000
-17.5%
79,755
-11.3%
0.01%0.0%
Q3 2021$1,683,000
-11.5%
89,897
-3.7%
0.01%
-9.1%
Q2 2021$1,902,000
-21.9%
93,374
-8.0%
0.01%
-26.7%
Q1 2021$2,435,000
-17.4%
101,461
-3.4%
0.02%
-21.1%
Q4 2020$2,948,000
+57.6%
105,063
+0.2%
0.02%
+35.7%
Q3 2020$1,871,000
+9.0%
104,806
-0.3%
0.01%
+7.7%
Q2 2020$1,716,000
+30.8%
105,109
+5.2%
0.01%
+8.3%
Q1 2020$1,312,000
+4.5%
99,872
+3.6%
0.01%
+20.0%
Q4 2019$1,256,000
-7.1%
96,440
+0.8%
0.01%
-9.1%
Q3 2019$1,352,000
+29.1%
95,668
-2.5%
0.01%
+37.5%
Q2 2019$1,047,000
-17.2%
98,169
-5.0%
0.01%
-20.0%
Q1 2019$1,265,000
+6.5%
103,320
+1.5%
0.01%0.0%
Q4 2018$1,188,000
-5.3%
101,759
-0.5%
0.01%0.0%
Q3 2018$1,254,000
-37.1%
102,219
-28.8%
0.01%
-28.6%
Q2 2018$1,994,000
+9.7%
143,483
+43.5%
0.01%
+7.7%
Q1 2018$1,817,000
-25.5%
100,019
+2.9%
0.01%
-18.8%
Q4 2017$2,438,00097,2070.02%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,825,262$138,6217.54%
Novo Holdings A/S 3,377,768$68,602,4684.28%
Parallel Advisors, LLC 3,724,664$75,647,9263.28%
TANAKA CAPITAL MANAGEMENT INC 35,539$7222.29%
Quantedge Capital Pte Ltd 251,312$5,104,1471.71%
S&T BANK/PA 346,306$7,0331.30%
Freshford Capital Management, LLC 249,000$5,057,1901.09%
Birchview Capital, LP 50,000$1,0160.72%
FAS Wealth Partners, Inc. 306,276$6,220,4660.70%
Bridge City Capital, LLC 60,824$1,2350.63%
View complete list of CORCEPT THERAPEUTICS INC shareholders